FDA Brief

Warning letters Food

FDA warning letter to

Thirsty Run LLC / US Royal Honey LLC

High riskIssued Jul 1, 2022Posted Jul 12, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA found hidden Viagra and Cialis ingredients in three royal honey products sold online as supplements and drugs.

What happened

FDA bought samples of the three royal honey products directly from the company's websites, thirstyrun.com and usroyalhoney.com, and reviewed those websites in June 2022. Laboratory analysis found undeclared tadalafil in Etumax Royal Honey for Him and Dose Vital Honey for Men, and undeclared sildenafil in Secret Miracle Royal Honey for Her. The websites also made claims that the products treat disease, which FDA says makes them unapproved new drugs.

What FDA found

  1. Two of the honey products contained tadalafil and one contained sildenafil, and none of these drug ingredients was declared on the label.

    Section 301(ll) of the FD&C Act [21 U.S.C. 331(ll)]
  2. Adding sildenafil or tadalafil to a food is a prohibited act, so selling these honey products in interstate commerce is illegal.

    Section 301(ll) of the FD&C Act [21 U.S.C. 331(ll)]
  3. Website claims that the products lower the risk of prostate illness or protect against bacterial infection make them drugs intended to treat disease.

    Section 201(g)(1) of the FD&C Act [21 U.S.C. 321(g)(1)]
  4. The products are not recognized as safe and effective for those uses, so they are new drugs sold without FDA approval.

    Sections 201(p), 301(d) and 505(a) of the FD&C Act [21 U.S.C. 321(p), 331(d), 355(a)]
  5. Secret Miracle Royal Honey for Her is labeled a dietary supplement, but a product containing sildenafil cannot legally be a dietary supplement.

    Sections 201(ff)(3)(B)(i) and (ii) of the FD&C Act [21 U.S.C. 321(ff)(3)(B)(i) and (ii)]
  6. FDA repeated its earlier finding that Pink Pussycat for Her contained undeclared sildenafil and said the company is responsible for making sure its products have no undeclared ingredients.

What FDA wants

FDA asks the company to write to CFSANResponse@fda.hhs.gov within 15 working days describing each step taken to fix the violations and prevent them from recurring, with supporting documents; if corrections cannot be finished in that time, the company must say why and give a date. If the company believes it is not violating the law, it must send its reasoning and supporting information.

Who should pay attention

  • online sellers of honey-based male and female enhancement products
  • retailers and online marketplaces that list royal honey supplements
  • quality and labeling reviewers who check supplement labels and website claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  2. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk